✦ LIBER ✦
Three-year recurrence-free survival in a patient with recurrent medulloblastoma after resection, high-dose chemotherapy, and intrathecal Yttrium-90-labeled DOTA0-D-Phe1-Tyr3-octreotide radiopeptide brachytherapy
✍ Scribed by Daniel Beutler; Pierino Avoledo; Jean-Claude Reubi; Helmut R. Mäcke; Jan Müller-Brand; Adrian Merlo; Thomas Kühne
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 208 KB
- Volume
- 103
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.